blindness and tirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO) Diabetes: Tirzepatide May Lower Risk
Pay in 4 interest-free payments of $5.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2














:quality(75):max_bytes(102400)/https://assets.iprofesional.com/assets/jpg/2025/12/608599.jpg)












